Related Experiment Videos
A new approach to accelerated drug-excipient compatibility testing
Jonathan L Sims1, Judith A Carreira, Daniel J Carrier
1GlaxoSmithKline R & D, New Frontiers Science Park, Harlow, Essex, UK. jon_sims-1@gsk.com
Pharmaceutical Development and Technology
|May 23, 2003
Summary
A new method rapidly predicts drug degradation and interactions, mimicking months of storage testing in just one hour. This accelerates drug-excipient compatibility screening for faster pharmaceutical development.
Area of Science:
- Pharmaceutical Sciences
- Analytical Chemistry
- Drug Development
Background:
- Accelerated storage testing is crucial for predicting drug stability but is time-consuming.
- Understanding drug-excipient interactions is vital for formulation development.
- Current methods for assessing degradation and interactions can take up to a month.
Purpose of the Study:
- To develop a rapid method for predicting drug degradants and probing drug-excipient interactions.
- To significantly reduce the time required for stability testing compared to traditional methods.
- To establish a practical and reliable screening technique for pharmaceutical formulations.
Main Methods:
- Investigated various stressing methods to mimic accelerated degradation.
- Developed a novel technique for qualitative prediction of degradants.
- Utilized a solid dosage form of drug substance SB-243213-A for testing.
- Compared results against accelerated storage testing at 50 degrees C.
Main Results:
- The developed method successfully mimicked one month of accelerated degradation in just one hour.
- Identified two oxidative impurities formed from drug substance SB-243213-A degradation.
- The method demonstrated suitability for automated analysis and multi-sample stressing.
- Achieved degradation levels comparable to three months of storage testing within the rapid timeframe.
Conclusions:
- The novel method offers a significantly faster alternative to conventional stability testing.
- This technique is ideal for efficient drug-excipient compatibility screening.
- The developed approach accelerates the prediction of drug degradation pathways and impurity formation.